Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Lifastuzumab vedotin

(Synonyms: RG-7599, NaPi2b-ADC, DNIB-0600A, DNIB0600A) Copy Product Info
🥰Excellent

Synonyms: RG-7599, NaPi2b-ADC, DNIB-0600A, DNIB0600A

Catalog No. T9901A-025 Copy Product Info
🥰Excellent
Lifastuzumab vedotin is an antibody-drug conjugate (ADC) that blocks cell division by inhibiting tubulin polymerization, with potential applications in the research of non-small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (PROC).
Lifastuzumab vedotin
Cas No. 1401812-88-1
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$2452-4 weeks2-4 weeks
5 mg$5352-4 weeks2-4 weeks
10 mgPreferential2-4 weeks2-4 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Lifastuzumab vedotin is an antibody-drug conjugate (ADC) that blocks cell division by inhibiting tubulin polymerization, with potential applications in the research of non-small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (PROC).
SynonymsRG-7599, NaPi2b-ADC, DNIB-0600A, DNIB0600A
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal, ADC
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
MMAE
Antigen Details
Gene ID
Uniprot ID
TargetNaPi2b/SLC34A2
Chemical Properties
Cas No.1401812-88-1
Antibody Information
IsotypeIgG1
Storage & Solubility Information
StorageStore at low temperature Store at -20°C Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion
Related Tags: